Pilot Study of Therapeutic Vaccination by Leukemic Blasts in Vitro Differentiated Dendritic Cells From Patients With Acute Myelogenous Leukemia in Complete Remission.
Latest Information Update: 18 Sep 2021
Price :
$35 *
At a glance
- Drugs Acute myeloid leukaemia vaccine (Primary)
- Indications Acute myeloid leukaemia
- Focus Adverse reactions
- 13 May 2011 Biomarkers information updated
- 12 May 2011 Actual end date (May 2011) added as reported by ClinicalTrials.gov.
- 12 May 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.